leuprorelin mesylate

Spain

Drugs containing this active substance

  • CAMCEVI 42 MG PROLONGED-RELEASE INJECTABLE SUSPENSION

    It is used to treat adult men with metastatic hormone-dependent prostate cancer or high-risk non-metastatic prostate cancer when combined with radiation therapy.

    Form: suspension for injection, prolonged release

    Active substance Dosage
    leuprorelin mesylate 48,05 mg

    ATC: L02A L02AE L02AE02

    Manufacturer: Accord Healthcare S.L.U.